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Abstract.  Using pharmacological (Simpson,  L. L., 
1980, J.  Pharmacol.  Exp.  Ther.  212:16-21)  and au- 
toradiographic techniques (Black, J.  D., and J.  O. 
Dolly,  1986, J.  Cell Biol.,  103:521-534),  it has been 
shown that botulinum neurotoxin (BoNT) is translo- 
cated across the motor nerve terminal membrane to 
reach a postulated intraterminal target. In the present 
study, the nature of this uptake process was inves- 
tigated using electron microscopic autoradiography. It 
was found that internalization is acceptor-mediated and 
that binding to specific cell surface acceptors involves 
the heavier chain of the toxin. In addition, uptake was 
shown to be energy and temperature-dependent and to 
be accelerated by nerve stimulation, a treatment which 
also shortens the time course of the toxin-induced neu- 
roparalysis. These results, together with the observa- 
tion that silver grains were often associated with endo- 
cytic structures within the nerve terminal, suggested 
that acceptor-mediated endocytosis is responsible for 
toxin uptake. This proposal is supported further by the 
fact that lysosomotropic agents, which are known to 
interfere with the endocytic pathway, retard the onset 
of BoNT-induced neuroparalysis and also affect the 
distribution of silver grains at nerve terminals treated 
with L~5I-BoNT. Possible recycling of BoNT acceptors 
(an important aspect of acceptor-mediated endocytosis 
of toxins) at motor nerve terminals was indicated by 
comparing the extent of labeling in the presence and 
absence of metabolic inhibitors. On the basis of these 
collective results, it is concluded that BoNT is inter- 
nalized by acceptor-mediated endocytosis and, hence, 
the data support the proposal that this toxin inhibits 
release of acetylcholine by interaction with an intracel- 
lular target. 
T 
HE  mechanism  of action  of botulinum  neurotoxin 
(BoNT) l  has  been  shown,  using  pharmacological 
(44) and autoradiographic (1, 11, 12) techniques, to in- 
volve at least one additional step after binding to specific cell 
surface acceptors, i.e., internalization. For a large protein, 
such as the BoNT molecule, to cross the hydrophobic lipid 
bilayer enclosing the motor nerve terminal, a high energy 
barrier must be overcome. Several possible means of achiev- 
ing this have been discussed (45):  (a) Toxin could enter the 
cytosol directly by means of an active mechanism inherent 
in the molecule, (b) uptake might be accomplished by an ac- 
tive process involving the cell membrane such as endocyto- 
sis, or (c) a combination of both these possibilities. Based 
on indirect evidence (21, 44, 46, 47), the process of acceptor- 
mediated endocytosis has been implicated in the entry of 
BoNT into the cytosol of target cells. Animal cells use this 
process to take up nutritional and regulatory factors from the 
extracellular fluid (16, 33);  the  internalization process  is 
1. Abbreviation used in this paper:  BoNT, botulinum neurotoxin. 
effectively  coupled to binding and has a half-time of <10 min 
at 37°C. It involves initial binding of the ligand to mobile ac- 
ceptors which are distributed randomly on the cell surface, 
with subsequent clustering of  the ligand-acceptor complexes 
in specialized regions of the plasma membrane known as 
coated pits (37). The pits then invaginate to form coated vesi- 
cles which, as they move deeper into the cytoplasm, shed 
their clathrin (35) coats (15-60 s) (36) and fuse with one an- 
other to form larger, smooth-surfaced vesicles called endo- 
somes. The latter are often surrounded by small tubular or 
round vesicular profiles that can  form anastomosing net- 
works (15, 34).  An important characteristic of these struc- 
tures is their low internal pH (51). This is thought to induce 
dissociation of ligands  from their  acceptors;  hence,  this 
vesicle-plus-tubule complex has been named compartment 
of uncoupling of receptors and ligands, or CURL (15). The 
ligands accumulate in the endosomal lumen, while the ac- 
ceptors are concentrated in the membrane of an attached 
tubular structure. The vesicular part may deliver dissociated 
ligands to lysosomes for degradation or direct them to some 
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braneous tubular structures, on the other hand, are thought 
to recycle acceptors to the plasma membrane (8). 
A  number of invasive agents, such as enveloped viruses 
and bacterial toxins, which introduce their genomes or toxic 
subunits  into  the  cytosol,  appear  to  use  the  process  of 
acceptor-mediated endocytosis to  reach their intracellular 
targets. In the virus systems (toga viruses, orthomyxo vi- 
ruses, and rhabdo viruses), the low pH of the endosomes in- 
duces a conformational change in the viral spike glycopro- 
teins; this results in the fusion of the viral membrane with 
the limiting membrane of the endosome and release of the 
nucleocaspid into the cytoplasm (25).  Similarly, in the case 
of bacterial toxins (e.g., diphtheria toxin), the low pH in the 
endosome induces a conforrnational change in the molecule 
that facilitates the passage of an active fragment across the 
vesicular membrane (2,  13). 
The relevance of such findings to the mechanism of access 
of BoNT to its intracellular target lies in the similarities in 
overall structure and action of the BoNT molecule and other 
bacterial or plant toxins. The "nicked" BoNT molecule con- 
sists of two heterologous polypeptides linked by a disulfide 
bond (7).  When the disulfide bond is reduced, the heavy 
(Mr ,o100,000) and light (Mr ,050,000)  chains can be sepa- 
rated using denaturing agents (e.g., urea or guanidine) (23). 
Several  bacterial  (e.g.,  cholera,  diphtheria,  and  tetanus 
toxins) and plant (abrin and ricin) toxins as well as some gly- 
coprotein hormones, which appear to act intraceUularly,  also 
consist of two heterologous components (30, 53). They seem 
to have a common strategy of access to their targets; one of 
the polypeptides binds to an acceptor on the external surface 
of the cell, while the other expresses its biological activity 
intracellularly. For BoNT types A and B, it has been shown 
that binding to  acceptors  on rat  cerebrocortical  synapto- 
somes is mediated by the heavier chain (22,  55).  Interest- 
ingly, tetanus toxin which, like BoNT, is thought to bind to 
acceptors in the central nervous system by its larger subunit 
(27,  52),  is  retarded  from binding  at the  neuromuscular 
junction by fragment C  of the toxin (part  of the heavier 
subunit) (48). 
In this study, the proposal that BoNT, like other molecules 
of similar  structure and mode of action,  is  taken up  by 
acceptor-mediated endocytosis was investigated using elec- 
tron microscopic autoradiography. BoNT is shown to bind to 
cell surface acceptors on motor neurons (1) through its heav- 
ier chain, resulting in uptake by an energy- and temperature- 
dependent process. This internalization is enhanced by nerve 
stimulation and modified by drugs (lysosomotropic agents) 
known to  affect acceptor-mediated  endocytosis  (31) and, 
also,  to  delay  the  onset  of  BoNT-induced  blockade  of 
neurotransmission, maintaining the  toxin at an  antitoxin- 
sensitive site (44, 46, 47). 
Materials and Methods 
Toxins 
Preparations (unlabeled and 125I-labeled) of BoNT type A (1) and of its iso- 
lated larger chain (55) were kindly provided by Dr. R. Williams of this labo- 
ratory. The polypeptides of BoNT were separated by QAE-Sephadex anion- 
exchange chromatography in the presence of dithiothreitol and urea (23). 
The heavy chain was then dialyzed against 0.02 M sodium phosphate buffer 
(pH 7.2)  for 48 h before use in competition experiments with ~25I-BoNT. 
Tetanus toxin, isolated from Clostridium tetanii (52), was kindly provided 
by Dr. P. D. Walker (Wellcome Labs, Beckenham, Kent, England). 
Tissue Labeling 
All studies were carded out in vitro.  Mouse hemidiaphragms were in- 
cubated with t25I-BoNT under different conditions and then washed at 4°C, 
before being processed for electron-microscopic autoradiography as de- 
scribed in the preceding paper (1). Nonspecific binding was determined in 
control samples labeled in the presence of  excess nonradioactive BoNT. The 
energy-dependence of the internalization process was investigated using 
tissue that was pretreated for 20-30 min at 22"C with Na azide (15 raM) 
or dinitrophenol (0.5  raM) before labeling with t25I-BoNT. To study the 
temperature-dependence  of  toxin internalization, samples were equilibrated 
in Krebs-Ringer's solution at 4 ° and 22°C before incubation with radiola- 
beled BoNT in the latter buffer for 2 h at each of these temperatures. The 
effects of the larger polypeptide of BoNT on the binding and internalization 
of t25I-BoNT were studied by incubating mouse hemidiaphragms in Krebs- 
Ringer's solution containing 10 nM mI-BoNT and a 50-fold excess of the 
larger chain, in the presence and absence of 15 mM Na azide. Likewise, 
the action of tetanus toxin was observed in autoradiograms of tissue pre- 
treated for 1 h at 22°C with 0.9 or 1.0 IxM tetanus toxin in Krebs-Ringer's 
solution, followed by incubation with 10 or U nM t25I-BoNT for 2 h. 
To examine the internalization step of  toxin-induced neuroparalysis, sam- 
pies of mouse diaphragm were labeled at 22°C for 90 min with ~I-BoNT 
in the absence of Ca  ÷÷ (+2 mM EGTA) or in the presence of the lysoso- 
motropic agents: methylamine (6 raM), ammonium chloride (6 mM), or 
ehloroquine (50 ~tM or 2 raM). The effect of nerve stimulation on toxin up- 
take was studied by incubating two mouse hemidiaphragms (dissected with 
the phrenic nerve intact) in Krebs-Ringer's solution/0.5 % bovine serum al- 
bumin (BSA) (gassed continuously with a fine stream of 95% 02/5% COz) 
containing 10 nM t~I-BoNT;  one of these was stimulated electrically at 0.25 
Hz throughout the  incubation period,  until  complete blockade of neu- 
rotransmission was observed (150 min at 22°C). 
Analysis of  Autoradiographic Data 
Electron-microscopic autoradiograms were analyzed quantitatively as fol- 
lows: photographs were taken of  at least 20-30 endplates from each prepara- 
tion, at a magnification of 3,600; prints were then prepared at a magnifica- 
tion of 19,600 and the nerve terminal membrane lengths were determined 
(1). The grains detectable on the plasma membrane and within the terminal 
cytoplasm (where applicable) were counted and expressed per unit length 
of membrane measured. To quantitate the extent of internalization of radio- 
activity under different conditions, silver grains on or within 60-70 nm of 
the membrane (see reference 1, section on resolution of  the autoradiographic 
technique used) and grains in the cytoplasm were counted separately, and 
expressed as a percentage of the total associated with the nerve terminals. 
Results 
Energy- and Temperature-dependence  of  the 
Internalization of  Radioactivity at Motor Nerve 
Terminals Labeled with uSI-BoNT 
Autoradiograms of murine motor nerve terminals treated 
with 125I-BoNT in vitro showed a saturable deposition of sil- 
ver grains on the terminal plasma membrane and also within 
the cytoplasm (1). When hemidiaphragms were pretreated 
with the inhibitor of mitochondrial oxidative phosphoryla- 
tion Na azide (15 mM) and then incubated with the radiola- 
beled toxin, silver grains were observed only on the nerve 
terminal plasma membrane (Fig. 1 a). Thus, internalization 
of radioactivity was prevented totally (90%  of the grains 
were found on the membrane itself and the remainder, which 
could arise from expected scatter,  within 150 nm of the lat- 
ter). When samples of tissue were incubated for 90 min with 
low toxin concentrations (e.g., 1.5 nM), the extent of label- 
ing was the same at azide-treated and untreated nerve termi- 
nals (Table I). However, at higher toxin concentrations (e.g., 
15 or 35 nM), Na azide-treated terminals showed only 90% 
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Terminals by leSl-BoNT under Different Conditions 
Extent of labeling* in Na azide- 
Toxin concentration  treated samples  relative to controls 
nM, 90 rain  % 
1.5  104 
15.0  90 
35.0  90 
Incubation with 
15 nM 125I-BoNT 
mm 
20  92 
90  9O 
150  80 
* This was quantified  by counting the number of grains in autoradiograms  of 
mouse hemidiaphragms labeled with ~251-BoNT. Using ",,30 endplates from 
each sample, the total number  of grains  therein (70-160) was determined.  The 
total length of nerve terminal plasma membrane from tissue treated with Na 
azide was measured by digitization  and the number of grains per micrometer 
was calculated;  this is expressed  relative  to that measured similarly  for control 
specimens where grains both on the plasma membrane and in the cytoplasm 
were included. 
Figure 1. Effect of metabolic inhibitors on the uptake of t25I-BoNT 
into the murine nerve terminal. Nerve-muscle preparations were 
preincubated for 20-30 min at 22°C with Krebs-Ringer's solution 
containing 15 mM Na azide or 0.5 mM dinitrophenol. The tissues 
were  then  incubated with  ~2~I-BoNT (11  nM)  in the appropriate 
preincubation medium for 90 min (at 22°C) and washed extensively 
in the same solutions (six changes, 5 min each) before processing 
for electron microscopic autoradiography. Slides were developed 
after 3-wk exposure at 4°C. Silver grains in the resultant autoradio- 
grams show the location of acceptors labeled with toxin in the pres- 
ence of azide (a) or dinitrophenol (b). 
of the labeling observed in untreated samples. To determine 
whether  the length of incubation also contributed to these 
different extents of labeling seen, nerve-muscle preparations 
were incubated at 22°C  with  15 nM  125I-BoNT  for various 
periods in the presence and absence of Na azide. Even after 
20 rain, a reduction of 8 % was observed in Na azide-treated 
samples; this increased to 10 and 20% after 90 and 150 min, 
respectively (Table I). Clearly, the length of incubation ac- 
centuated the difference in the extent of labeling under the 
two conditions. Dinitrophenol (0.5 mM),  another inhibitor 
of energy production, also prevented uptake of radioactivity 
into the nerve terminal (Fig. 1 b). Silver grains were detect- 
able on all unmyelinated areas of the nerve terminal plasma 
membrane in treated samples, as previously observed in tis- 
sue  preincubated  with  azide  (1).  Since  both  azide  and 
dinitrophenol inhibit the production of ATP within the cell, 
the  internalization  of  L~-5I-labeled toxin  appears  to  be  an 
energy-requiring process. 
The  effect of low temperature on this energy-dependent 
uptake  process  was  studied  by  exposing  mouse  hemidi- 
Figure 2.  Temperature dependence of the binding and internaliza- 
tion  of  t2~I-BoNT at  the  motor  nerve  terminal.  Pieces  of di- 
aphragm were pre-equilibrated with Krebs-Ringer's solution at 4°C 
and then incubated for 2 h in 0.5 ml Krebs-Ringer's solution con- 
raining 11 nM ~25I-BoNT. The tissue was then washed, fixed in 2 % 
glutaraldehyde for 75 min (at 4°C), and processed for electron mi- 
croscopic autoradiography. Control preparations were treated simi- 
larly but at room temperature. Slides were developed after 3-wk ex- 
posure.  (a) Nerve terminal treated with  ~5I-BoNT  at 4°C.  Note 
the reduced number of silver grains associated with the synaptic 
bouton (30% relative to controls, see Table II) and the absence of 
internalized radioactivity. (b)  Control  sample treated  with  1251- 
BoNT at 22°C  showing membrane-bound and internalized silver 
grains in a ratio of ~60:40. 
Black and Dolly Acceptor-mediated Endocytosis of Botulinum Neurotoxin  537 Table II. Effects of Various Agents on the Binding 
and Internalization of 12JI-BoNT at the Murine Motor 
Nerve Terminal 
Distribution of grains 
Relative number  with respect to the 
of grains per  plasma membrane* 
micrometer  % of total 
plasma 
Treatment  membrane"  On  Within 
% 
11  nM  125I-BoNT 
22°C  100  60  40 
4°C  30  100  0 
10 nM  ~2SI-BoNT 
Control  100  65  35 
BoNT large subunit 
(0.5  I~M)  0  -  - 
Na azide (15  mM)  100  100  0 
Na azide (15 mM) +  large 
subunit of BoNT 
(0.5  ItM)  0  -  - 
11  nM  ~25I-BoNT 
Control  100  61  39 
Tetanus toxin (0.9  I~M)  31  61  39 
10 nM  ~25I-BoNT 
Control  100  56  44 
Tetanus toxin (1.0 ~tM)  41  59  41 
10 nM 125I-BoNT 
Control  100  61  39 
Nerve stimulation  100  41  59 
15 nM 125I-BoNT 
Control  100  57  43 
-Ca  +* (+2 mM EGTA)  106  54  46 
20 nM 125I-BoNT 
Control  ND  59  41 
Chloroquine (50 gM)  ND  50  50 
Methylamine (6 mM)  ND  73  27 
Ammonium chloride 
(6 raM)  ND  74  26 
* Using electron  microscopic  autoradiograms,  the  total  number of grains 
(0-200) observed on the nerve terminal membrane and enclosed within it were 
counted in a minimum  of 30 endplates from each sample. The calculated num- 
ber of grains per unit length of membrane (see legend to Table I) for treated 
samples was expressed relative to that of control specimens in each experiment. 
~: The extent of internalization was quantified by counting separately the num- 
ber of grains on the plasma membrane (i.e., within 70 nm) and within the ter- 
minal in at least 30 endplates from each sample. 
ND, not determined. 
aphragms to t25I-BoNT at 4°C for 2 h. Under these condi- 
tions, the toxin still interacted with the nerve terminal mem- 
brane  as  silver grains  could be  detected in  the  resultant 
autoradiograms (Fig. 2 a).  However, the extent of labeling 
was only 30%  (determined by quantitative analysis of the 
results as described in Materials and Methods; see Table II) 
of that seen in controls incubated at room temperature (Fig. 
2 b). The internalization of toxin was inhibited completely 
at 4°C, silver grains being found on the plasma membrane 
(or very close to it) but not inside it. 
Effect of the Larger Polypeptide on the Binding 
and Internalization of ~I-BoNT 
The heavy chain (Mr 97,000),  which retained only 0.1% of 
the toxicity of  the native protein (55), was tested for its ability 
to compete with the binding of uSI-BoNT. A 50-fold excess 
(0.5 pM) (lower concentrations were not tested) was effective 
in totally preventing the binding of t~5I-BoNT both in the 
absence (Fig. 3) and presence of Na azide. Its inhibition of 
the internalization of radioactivity in samples labeled with 
125I-BoNT in the absence of Na azide (Table 1/) emphasizes 
that toxin binding is a prerequisite for translocation into the 
nerve terminal.  This  complete inhibition  of binding  and 
internalization of toxin by the larger chain suggests that (a) 
the latter is involved directly in saturable binding to accep- 
tors on the nerve terminal membrane and (b) it is responsible 
indirectly (and possibly also directly) for the uptake of  radio- 
activity into the cytoplasm. 
Action of Tetanus Toxin on the Binding 
and Internalization of ~I-BoNT 
The overall pharmacological effects of BoNT and tetanus 
toxin (both Clostridial neurotoxins) are qualitatively very 
similar, although BoNT is 1,000 times more potent at suscep- 
tible peripheral synapses (18) and some differences have been 
detected in their detailed action (14).  A  fivefold excess of 
tetanus toxin had no effect on the binding or uptake of ~25I- 
BoNT at motor nerve terminals (data not shown); however, 
a  larger (80-100-fold) excess inhibited the binding by 60- 
70%  (Table II).  The distribution of mI-BoNT labeling of 
the motor nerve terminal in the presence of tetanus toxin was 
the same as that observed in control samples; for example, 
tetanus toxin did not interact solely with sites located away 
from the active zones or along the axonal plasma membrane. 
The ratio of membrane-bound to internalized silver grains 
was also unaffected by tetanus toxin, indicating that it does 
not interact only with a population of sites responsible for 
mediating  toxin uptake into the cytosol.  Collectively, the 
results suggest that tetanus toxin interacts with some of the 
acceptors for BoNT, either directly or indirectly; however, 
the  significance  of  this  is  questionable  as  treatment  of 
nerve-muscle preparations with the binding fragment C (at 
a concentration that antagonizes the action of tetanus toxin) 
does not prevent the blockade of transmission induced by 
0.01 mM BoNT A  (48). 
Nerve Stimulation Increases the Uptake 
but not the Binding of n3I-BoNT at the Motor 
Nerve Terminal 
In this experiment, both test and control preparations were 
set up identically-each hemidiaphragm was attached to an 
electrode and immersed in a bath of Krebs-Ringer's solu- 
tion/0.5%  BSA containing  ~25I-BoNT (10 nM)  and  gassed 
continuously with 95% 02/5% CO2 at 22°C, but only one 
of these was electrically stimulated. The twitch response in 
this preparation was abolished after 150 min (Fig. 4 a). After 
4-mo exposure of sections cut from test and control blocks, 
silver grains were seen at nerve endings and on unmyelinated 
axons in both preparations (Fig. 4 b). Grains at the nerve ter- 
minal  appeared  on  the  plasma  membrane  and  in  the 
cytoplasm, indicating that uptake of toxin had occurred but, 
interestingly, the ratio of membrane-bound to internalized 
grains was different in unstimulated and stimulated speci- 
mens. In the former, 61% of the grains were located on the 
plasma membrane and 39 % within the terminal (Table II). 
This accords very closely with the ratio obtained in the initial 
localization experiments (62%  : 38%; see reference 1). In 
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were  on  the  membrane  and  59%  in  the  nerve  terminal 
cytoplasm; a 50% increase in the relative uptake of radioac- 
tivity, therefore, became apparent upon stimulation although 
the total number of grains per micrometer of membrane re- 
mained unchanged (Table II). 
Effect of Ca  ÷÷  Deprivation and of 
Lysosomotropic Agents on the Uptake of U~I-BoNT 
into the Nerve Terminal 
All  of the  data presented,  together with  pharmacological 
findings  (45-47),  suggest  that  acceptor-mediated endocy- 
tosis is responsible for toxin internalization. To obtain fur- 
ther evidence for this,  the effects of incubation conditions 
and  drugs  known to alter this process were studied.  Ca  ÷÷ 
deprivation has been shown, in a number of cases, to prevent 
certain steps in the endocytic pathway (31). Likewise, lyso- 
somotropic agents  such  as  chloroquine,  ammonium  chlo- 
ride, and methylamine interfere with this process by raising 
the intravacuolar pH of lysosomes and other acidic compart- 
ments, thus preventing ligand-acceptor dissociation and/or 
lysosomal degradation (9,  10, 24). These agents are known 
to inhibit the action of diphtheria toxin (24), modeccin (41), 
certain  viruses  (19),  and  many  other  substances  that  act 
intracellularly. Most importantly, Ca  +÷ deprivation or lyso- 
somotropic agents are known to delay the onset of BoNT- 
induced blockade of neurotransmission in phrenic nerve- 
hemidiaphragm preparations (44, 46, 47) and to maintain the 
toxin at an unidentified site, where it is sensitive to antitoxin 
antibodies. 
Ca  ++ Deprivation 
Nerve-muscle preparations  were exposed to  ~25I-BoNT in 
Krebs-Ringer's solution or the latter lacking Ca  ÷÷ and con- 
Figure  3.  Inhibition  of  usI- 
BoNT binding to nerve termi- 
nals by the larger polypeptide 
of BoNT. Mouse diaphragm 
was  incubated  with  0.5  ml 
Krebs-Ringer's  solution con- 
taining  125I-BoNT (10  nM) 
and  a  50-fold excess  of its 
larger  subunit  (a).  After 90 
min at 22°C, the samples were 
washed  and  fixed  in  2% 
glutaraldehyde.  Control  sec- 
tions  were  treated  similarly 
but in the absence of the large 
subunit of the toxin (b). Auto- 
radiograms were prepared as 
before. 
raining 2 mM EGTA; quantitative analysis of the binding of 
labeled toxin to the nerve terminal was then carried out at 
the ultrastructural level.  The number of silver grains ob- 
served at endplates was unaltered by removal of Ca  ++ (Table 
II). This suggests that the protective effect of Ca  ++ depriva- 
tion  on  the  time  course  of toxin-induced neuroparalysis 
cannot be attributed to inhibition of the binding step,  Sur- 
prisingly,  the  internalization  step  was  also  unaffected  in 
preparations incubated in Ca÷+-free medium, the proportion 
of cytoplasmic silver grains being the same in test and con- 
trol preparations (Table II; Fig.  5, a  and b). 
Effect of  Lysosomotropic Agents 
Mouse diaphragm  preparations  were treated with chloro- 
quine,  ammonium chloride, or methylamine at concentra- 
tions  known  to  interfere  with  the  toxins  neuroparalytic 
effects  (46,  47),  followed  by  the  addition  of  ~25I-BoNT. 
Qualitative  analysis  of the  resultant  autoradiograms  sug- 
gested that binding of toxin to the terminal membrane was 
unaffected by these agents.  Although internalization of la- 
beled toxin was not prevented fully by any of these drugs, 
changes in the ratio of membrane-associated to internalized 
grains were apparent (Table 1I). In chloroquine-treated sam- 
ples, there were slightly more (20%) internalized grains rela- 
tive to control untreated preparations; the grains were quite 
often associated with vacuole-like structures. In the presence 
of a higher concentration (2 raM) of chloroquine (a level at 
which the drug itself causes neuromuscular blockade; [46]), 
extensive vacuolation was detected in the cytoplasm of the 
nerve endings (data not shown). Under the latter conditions, 
it  could  be  said  (within  the  limitations  in  resolution  of 
the autoradiographic technique) that the internalized silver 
grains  were  associated  almost  exclusively with  vesicular 
structures; areas devoid of vacuoles were unlabeled. 
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uptake  of mI-BoNT into the  nerve terminal.  A  mouse hemidi- 
aphragm was attached to an electrode and immersed in 8 ml Krebs- 
Ringer's solution/0.5%  BSA, gassed gently with 95%  O2/5%CO2 
at 22°C. It was stimulated electrically at 0.25 Hz for 15 min before 
the addition of nSI-BoNT to a final concentration of 10 nM. When 
complete blockade of  neurotransmission was observed, the hemidi- 
aphragm was washed thoroughly with Krebs-Ringer's solution/BSA 
at 4°C, fixed, and processed for electron microscopic autoradiogra- 
phy. A control preparation was treated similarly but was not stimu- 
lated. Slides were exposed for 4 mo at 4°C. (a) Trace showing mus- 
cle contraction in response to nerve stimulation (see reference 44) 
in  the  presence  of  t25I-BoNT. (b)  Autoradiograrn  showing  the 
effect of stimulation on the distribution of ~25I-BoNT  molecules at 
the motor nerve terminal. Silver grains are seen on the nerve termi- 
nal membrane and in the cytoplasm but the proportion of internal- 
ized radioactivity is greater than in controls (by 50%, see Table II). 
In  the  presence  of  ammonium  chloride,  however,  the 
proportion  of membrane-associated to  internalized  silver 
grains was 74 % :26 %; thus, relative to control preparations, 
uptake of radioactivity was reduced by ,035 % (Table II). Un- 
der these conditions, vacuolation was extensive in the termi- 
nal cytoplasm and the majority of internalized silver grains 
were  associated  with  vesicular  structures.  Similar  results 
were obtained in samples treated with methylamine (Table 
II); the extent of uptake was reduced by ,033%  relative to 
controls (only 27 % of the grains associated with the nerve 
terminal  were  in  the  cytoplasm).  As  seen in  ammonium- 
chloride-treated samples, many internalized grains were as- 
sociated with endocytic vesicles. This inhibitory action of the 
short chain amines (ammonium chloride and methylamine) 
on  the  internalization  of BoNT accords  with their  known 
ability to prevent the endocytic uptake of ¢t2-macroglobulin 
and epidermal growth factor into target cells (28); however, 
the incomplete inhibition with the toxin may indicate limited 
uptake of toxin by an  additional  route that  would  be less 
likely to cause neuroparalysis. 
Discussion 
Autoradiograms of motor nerve endings  treated  with  ~25I- 
BoNT show that toxin molecules, or fragments thereof, are 
internalized; silver grains can be observed both on the mem- 
brane and within the terminal (1). The importance of this up- 
take is emphasized by a  number of studies in which it was 
shown that (a) there is a latent period between irreversible 
binding of toxin and onset of paralysis (4); (b) paralysis oc- 
curs  more rapidly  when  nerves  are  stimulated  frequently 
(21), a treatment that also increases toxin uptake (Table II); 
(c)  antitoxin  antibodies  can  inactivate  toxin  bound  to  the 
nerve membrane but cannot prevent paralysis subsequent to 
this stage of the intoxication process (43). Collectively, these 
findings are in accordance with the possibility that toxin in- 
ternalization is a prerequisite for its blockade of neurotrans- 
mitter release. Nevertheless, it must be realized that, until 
the neurotoxic effects of BoNT can be demonstrated in a cell- 
free system, it cannot be stated conclusively that the target 
site for its action is located in the cytosol. 
Using electron microscopic autoradiography, it has been 
shown directly for the first time that  uSI-BoNT type A  is 
taken up  into the  nerve terminal by an acceptor-mediated 
process. Treatment of samples with an excess of the native 
neurotoxin (11, 12),  or of its larger subunit,  prevented the 
binding  of  radiolabeled  BoNT  and  no  grains  were  then 
detected  within  the  nerve terminal  cytoplasm.  Thus  bulk 
pinocytosis, which is nonsaturable (49), can be ruled out as 
the main mechanism of toxin entry. It would seem, therefore, 
that the binding step, demonstrated here to be mediated by 
the  heavier chain of BoNT,  is  essential  for translocation. 
This is also the case with other bacterial and plant toxins 
which act intracellularly. For example, the binding of diph- 
theria toxin to its acceptor is necessary for expression of its 
cytotoxicity; insensitive cell lines lack the acceptor (3). Like- 
wise, binding to carbohydrates containing galactose residues 
is required for the action of abrin and ricin as cells can be 
partially protected by the addition of galactose to the incuba- 
tion medium (32). 
The findings described in this paper also suggest that en- 
docytosis  is  involved  in  the  acceptor-mediated  uptake  of 
BoNT at motor nerve terminals. Firstly, as characteristic of 
this  process  (33),  the  internalization  step  for  BoNT  is 
energy- and temperature-dependent. Thus, it is unlikely that 
the toxin enters the cell by a mechanism dependent solely on 
the  molecule  itself;  the  requirement  of an  intact  plasma 
membrane points to the involvement of a  normally occur- 
ring  cellular  process.  In  addition,  the  structures  used  in 
acceptor-mediated endocytosis, i.e., coated pits, coated vesi- 
cles, endosomes, and prelysosomes (33),  are all present in 
nerve endings  (Fig.  6).  Moreover,  silver grains  in autora- 
diograms of nerve endings labeled with 125I-BoNT were of- 
ten  associated with the  membrane of endocytic  structures 
([1]; Fig. 6 d), lending further support to the above proposal. 
Another important characteristic of endocytosis at the nerve 
terminal is portrayed in the uptake of BoNT; nerve stimula- 
tion results in accelerated endocytosis (5) and this could ex- 
plain  the  increased  uptake  (by  50%)  of toxin  molecules 
The Journal of Cell Biology, Volume 103, 1986  540 Figure 5. Effect of Ca  .+ deprivation on the neural internalization of uSI-BoNT. (a and at) A piece of mouse diaphragm was preincubated 
in Ca*+-free  Krebs-Ringer's solution containing 2 mM EGTA for 15 min at 22°C. This was followed by incubation in 0.5 ml of the same 
buffer containing 15 nM ~25I-BoNT  for 90 min at 22°C. Extensive washing was carried out using Ca++-free Krebs-Ringer's solution before 
fixation in 2 % glutaraldehyde and preparation of the tissue for electron microscopic autoradiography. Arrows, intraterminal silver grains. 
(b) Control samples were treated in the same way except that normal Ringer's solution was used. 
bound to the presynaptic membrane after such treatment. 
Furthermore, this accords with the evidence that intoxication 
by BoNT occurs more rapidly on stimulating the nerve (21). 
These collective findings emphasize the likelihood of an in- 
tracellular target for BoNT, as well as support the involve- 
ment of acceptor-mediated endocytosis. In this process, the 
acceptors  serve to  selectively concentrate ligands  present 
in  the  extracellular fluid  (even if they occur in  very low 
amounts) on the plasma membrane so that efficient uptake 
takes place compared with bulk fluid pinocytosis (8). Hence, 
the presence of specific acceptors for BoNT at the nerve ter- 
minal, at relatively high content (1), could enable adequate 
amounts of the toxin to be internalized, even with the very 
low concentrations (10-~IM) known to be effective in block- 
ing neuromuscular transmission (44). 
Lysosomotropic agents,  known to affect the acidic corn- 
partments  (i.e.,  endosomes,  lysosomes) of the  endocytic 
pathway,  antagonize the actions of numerous protein toxins 
(16, 24,  31). Interestingly, in cases such as that of cholera 
toxin where endocytosis is  apparently not involved, these 
drugs (e.g., chloroquine) do not affect toxin action (see refer- 
ence 31). Further evidence for an involvement of endocytic 
vesicles of low pH in the internalization process is given by 
the report that, under artificial conditions in which the ex- 
tracellular medium is made acidic, both diphtheria toxin (38, 
39) and certain viruses (e.g., Semliki Forest virus [19, 25] 
and influenza virus [26]) enter target cells directly from the 
cell surface. It is envisaged that under normal conditions, 
these toxins and viruses gain access to their cytoplasmic tar- 
gets (without degradation in lysosomes) by abandoning the 
endocytic route at the endosome, which has a low pH but few 
or no degradation enzymes.  Such avoidance of lysosomal 
Black and Dolly Acceptor-mediated Endocytosis of Botulinum Neurotoxin  541 Figure 6. Structures of the motor nerve terminal involved in the process of acceptor-mediated endocytosis. Coated pits (a), coated vesicles 
(b), endosomes (c), and prelysosomes (cO are present (arrows) in these cholinergic nerve terminals showing that acceptor-mediated en- 
doeytosis can take place therein.  (d) Nerve endings from a hemidiaphragm preparation treated with ~25I-BoNT in which silver grains can 
be seen associated with the membrane of intracellular vesicles (arrows). 
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ported by reports that both BoNT (50) and diphtheria toxin 
(6) must be nicked, before application, if maximum toxicity 
is to be expressed. Additionally, in the case of Sendai virus, 
the fusion protein must be proteolytically cleaved to be ac- 
tive. The rich supply of proteolytic enzymes in lysosomes 
would lead one to expect that, if BoNT entry involved the 
lysosomal compartment, both nicked and unnicked forms of 
the molecule would be equally potent (31). 
Based on this postulated endocytic route for BoNT, the an- 
tagonistic effects of toxin-induced neuromuscular paralysis 
by the lysosomotropic agents chloroquine, ammonium chlo- 
fide, and methylamine can now be explained. In the presence 
of chloroquine, BoNT remains at an antitoxin sensitive site 
(46). Autoradiograms of  motor nerve endings incubated with 
t25I-labeled  toxin  in  the  presence  of chloroquine showed 
that, under these conditions, the toxin still binds to the mem- 
brane and is subsequently internalized. Silver grains within 
the terminal were associated almost exclusively with vacuo- 
lar structures; therefore, to allow the antibodies to achieve 
their protective action they must have had access to the vesic- 
ular pool with which the toxin was associated. This could oc- 
cur in two ways:  antibodies could reach the same vesicles 
from the extracellular medium (17) and/or the toxin could be 
re-exposed to the surface of the cell (29). Given the known 
effects of chloroquine in other systems, the second scheme 
seems more likely (15). A possible explanation of events in 
the presence of the drug could, thus, be the following: the 
toxin still binds to extracellular acceptors and is taken up into 
endosomes. Because of the rise in the endosomal pH due to 
the presence of chloroquine, BoNT does not undergo the 
conformational change postulated to be required for entry 
into the cytoplasm. The acceptor-toxin complex is,  there- 
fore, returned to the cell surface intact where it is inactivated 
by antitoxin; this is based on the fact that the failure of a 
ligand to detach from its acceptor in the endosomal compart- 
ment may result in its return to the cell surface with recycling 
membrane patches (42).  Recycling of the BoNT acceptor 
was suggested by the presence of more silver grains in nerve 
endings exposed to t25I-BoNT (at least the higher concen- 
trations) in the absence than in the presence of metabolic in- 
hibitors (and thus inhibitors of  the energy-requiring recycling 
process) (see Table I). The short chain amines, ammonium 
chloride and methylamine, also maintain BoNT molecules at 
an  antitoxin-sensitive site  (47).  In  addition to raising  en- 
dosomal/lysosomal pH and thus preventing ligand-acceptor 
dissociation and lysosomal processing (10), these drugs are 
thought to prevent fusion of endosomes with lysosomes, pos- 
sibly explaining the net increase in the proportion of grains 
seen on the plasma membrane.  Collectively, the effects of 
lysosomotropic agents on the action of botulinum toxin (46, 
47) as well as on the distribution of molecules at the nerve 
terminal, together with their known actions in other systems, 
provide strong  evidence for the  involvement of acceptor- 
mediated endocytosis in the uptake of BoNT. 
Autoradiograms  of  nerve  terminals  treated  with  125I- 
BoNT in the absence of Ca  ++ showed that neither binding 
nor  internalization  is  affected,  despite  pharmacological 
studies (44) having shown that under these conditions toxin 
remains  accessible  to  antibodies.  The  lectins  abrin  and 
modeccin do not inhibit protein synthesis in the absence of 
Ca  ++ and ricin is less effective under these conditions (40). 
The protective effect of Ca  ++ deprivation in these cases is 
not due to reduced toxin binding to the cell membrane or to 
inhibition of internalization.  These results are compatible 
with the suggestion (31) that Ca  ++ efflux from intracellular 
compartments  is  required for toxin transport to the cyto- 
plasm.  Similarly, the lack of BoNT toxicity in the absence 
of Ca  ++ (44) could be attributed to its inability to enter the 
cytosol from the endosome. Williams (54) has shown that the 
extent  of  125I-BoNT binding  to  synaptosomes  is  not  ap- 
preciably different between pH 5 and 7; toxin could thus re- 
main bound to its acceptors within the acidic endosomes and 
be returned to the cell surface to be inactivated by antitoxin. 
The data presented here and elsewhere suggest strongly 
that acceptor-mediated endocytosis is involved in the uptake 
of BoNT into the nerve terminal. This proposal is viable in 
so far as the structures involved in this process are found at 
motor nerve terminals. Moreover, evidence that the toxin is 
taken up into an acidic compartment, from which it may gain 
access to the cytosol, is apparent from the demonstrated abil- 
ity of lysosomotropic agents to perturb the internalization 
and to delay the onset of BoNT-induced blockade of neu- 
rotransmission (46). The need for nicking of BoNT in the ex- 
pression of toxicity provides indirect evidence that it enters 
the cytoplasm from the endosome rather than a lysosome. In 
the case of other toxins and viruses, the low pH in the endo- 
some is believed to induce a conformational change in the 
protein (exposing hydrophobic regions) that results in trans- 
fer of an active fragment into the cytosol. It is interesting 
that, under these conditions, the heavier subunit of BoNT 
forms 1.8-nm channels in asolectin membranes (20) when a 
positive potential is applied across the membrane and the pH 
is low (~4.5) in the toxin-containing chamber. 
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